secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2025-12-31T23:59:59+00:00
Accession:  0001493152-25-029778
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lixte exchanges 2,700 Series C preferred for 700K common shares and 20% of Liora subsidiary
--------------------------------------------------------------------------------

- Orbit Capital Inc. exchanged 2,700 Series C Preferred shares for 700,000 Lixte common shares and 200 ordinary shares of Liora (20% of Liora).
- Upon closing, all Series C Preferred shares were cancelled and no longer outstanding.
- Lixte retained 800 ordinary shares of Liora after the exchange.
- Transaction was exempt from registration under Section 4(a)(2) and Regulation D.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000149315225029778/0001493152-25-029778-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000149315225029778/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-029778

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer